Genpact Limited (NYSE:G) received a $33.00 target price from analysts at Cowen and Company in a note issued to investors on Tuesday. The firm currently has a “buy” rating on the business services provider’s stock. Cowen and Company’s target price would suggest a potential upside of 15.59% from the company’s current price.
A number of other research firms also recently weighed in on G. BMO Capital Markets raised their price target on shares of Genpact Limited from $26.00 to $30.00 and gave the company a “market perform” rating in a report on Thursday, August 3rd. BidaskClub upgraded shares of Genpact Limited from a “buy” rating to a “strong-buy” rating in a report on Wednesday, June 28th. Zacks Investment Research upgraded shares of Genpact Limited from a “hold” rating to a “buy” rating and set a $33.00 price target on the stock in a report on Tuesday, August 8th. Wedbush restated an “outperform” rating and set a $33.00 price target on shares of Genpact Limited in a report on Wednesday, August 9th. Finally, Deutsche Bank AG raised their price target on shares of Genpact Limited from $26.00 to $28.00 and gave the company a “hold” rating in a report on Thursday, August 3rd. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $30.67.
Shares of Genpact Limited (NYSE G) traded down 2.99% during mid-day trading on Tuesday, reaching $28.55. 4,340,595 shares of the company were exchanged. The company has a market capitalization of $5.51 billion, a price-to-earnings ratio of 21.56 and a beta of 0.50. Genpact Limited has a 12 month low of $22.58 and a 12 month high of $31.93. The firm’s 50-day moving average is $28.50 and its 200-day moving average is $26.00.
Genpact Limited (NYSE:G) last released its quarterly earnings results on Wednesday, August 2nd. The business services provider reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.10. The business had revenue of $670.70 million for the quarter, compared to the consensus estimate of $642.68 million. Genpact Limited had a net margin of 10.22% and a return on equity of 23.33%. Genpact Limited’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.36 EPS. On average, equities analysts forecast that Genpact Limited will post $1.56 earnings per share for the current fiscal year.
In related news, insider Mohit Thukral sold 27,228 shares of the firm’s stock in a transaction on Tuesday, May 30th. The shares were sold at an average price of $27.21, for a total value of $740,873.88. Following the transaction, the insider now directly owns 68,845 shares in the company, valued at approximately $1,873,272.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.55% of the company’s stock.
Hedge funds have recently bought and sold shares of the company. Renaissance Technologies LLC bought a new stake in Genpact Limited during the first quarter valued at about $19,870,000. AQR Capital Management LLC raised its stake in Genpact Limited by 6.0% in the first quarter. AQR Capital Management LLC now owns 1,983,274 shares of the business services provider’s stock valued at $49,106,000 after buying an additional 112,723 shares in the last quarter. BNP Paribas Arbitrage SA raised its stake in Genpact Limited by 85.3% in the first quarter. BNP Paribas Arbitrage SA now owns 5,220 shares of the business services provider’s stock valued at $129,000 after buying an additional 2,403 shares in the last quarter. Cooke & Bieler LP raised its stake in Genpact Limited by 64.9% in the first quarter. Cooke & Bieler LP now owns 731,209 shares of the business services provider’s stock valued at $18,105,000 after buying an additional 287,828 shares in the last quarter. Finally, Montag & Caldwell LLC raised its stake in Genpact Limited by 31.5% in the first quarter. Montag & Caldwell LLC now owns 32,950 shares of the business services provider’s stock valued at $816,000 after buying an additional 7,884 shares in the last quarter. Institutional investors own 92.25% of the company’s stock.
About Genpact Limited
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
What are top analysts saying about Genpact Limited? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Genpact Limited and related companies.